{
  "ptid_time": "029_S_1073_2008-12-08",
  "img_path": "/data/qiuhui/data/adni/images/029_S_1073/2008-12-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 24,087 mm³, 7.8% above the reference mean. With a Z-score of 0.20 (57.8th percentile), this represents normal volume ; hippocampal volume measures 5,741 mm³, 25.3% below the reference mean. With a Z-score of -2.84 (0.2th percentile), this represents significant atrophy; whole brain volume measures 899,619 mm³, 12.6% below the reference mean. With a Z-score of -1.57 (5.9th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,715 mm³, 30.3% below the reference mean. With a Z-score of -2.34 (1.0th percentile), this represents significant atrophy; fusiform gyrus volume measures 12,086 mm³, 33.6% below the reference mean. With a Z-score of -3.79 (0.0th percentile), this represents profound atrophy; middle temporal gyrus volume measures 16,045 mm³, 21.8% below the reference mean. With a Z-score of -1.94 (2.6th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 67.7 years. Gender is Female. Education: 18 years. MMSE: 24.0. Logical Memory: 2.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 743.60 pg/mL (normal ); Total tau: 657.90 pg/mL (profound elevated); Phosphorylated tau: 68.84 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus) alongside moderately reduced whole brain and middle temporal gyrus volumes. The CSF biomarkers (normal Aβ but profoundly elevated T-tau and P-tau) suggest Alzheimer’s pathology despite normal amyloid levels, possibly indicating tau-predominant neurodegeneration. The MMSE score of 24 is borderline but aligns with cognitive impairment.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease variant with tau-predominant pathology)  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but atypical amyloid profile warrants caution in subtyping).",
  "timestamp": "2025-07-26T04:22:06.654151"
}